Re: Jarow JP et al.: Clinical trial design for the development of new therapies for non-muscle-invasive bladder cancer: Report of a food and drug administration and american urological association public workshop (urology 2014;83:262-265)

Urology

Volumn 84, Issue 2, 2014, Pages 494-495

  Amrhein, John ^a   Kamat, Ashish M ^b   Morales, Alvaro ^c  

^a McDougall Scientific Ltd   (Canada)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GEMCITABINE; INTERFERON;

CLINICAL TRIAL (TOPIC); DISEASE FREE SURVIVAL; DRUG DEVELOPMENT; FOOD AND DRUG ADMINISTRATION; HIGH RISK POPULATION; HUMAN; LETTER; MEDICAL SOCIETY; MYCOBACTERIUM BOVIS BCG; NON MUSCLE INVASIVE BLADDER CANCER; PRIORITY JOURNAL; TREATMENT RESPONSE; WORKSHOP;

CLINICAL TRIALS AS TOPIC; HUMANS; URINARY BLADDER NEOPLASMS;

EID: 84904988334     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2014.03.034     Document Type: Letter

References (5)

1. G. Steinberg, R. Bahnson, and S. Brosman et al. Efficacy and safety of valrubicin for the treatment of Bacillus Calmette-Guerin refractory carcinoma in situ of the bladder. The Valrubicin Study Group J Urol 163 2000 761 767
2. I.A. Sternberg, G. Dalbagni, and L.Y. Chen et al. Intravesical gemcitabine for high risk, nonmuscle invasive bladder cancer after bacillus Calmette-Guérin treatment failure J Urol 190 2013 1686 1691
3. E.C. Skinner, B. Goldman, and W.A. Sakr et al. SWOG S0353: phase II trial of intravesical gemcitabine in patients with nonmuscle invasive bladder cancer and recurrence after 2 prior courses of intravesical bacillus Calmette-Guérin J Urol 190 2013 1200 1204
4. H.M. Rosevear, A.J. Lightfoot, and K.K. Birusingh et al. Factors affecting response to bacillus Calmette-Guérin plus interferon for urothelial carcinoma in situ J Urol 186 2011 817 823
5. FDA/AUA Bladder Cancer Workshop. Clinical trial design issues: development of new therapies for non-muscle invasive bladder cancer 2013 Available at: http://www.aua2013.org/webcasts/fda-bladder-cancer-workshop.cfm. Accessed October 7, 2013.